Should Vanguard Mega Cap ETF (MGC) Be on Your Investing Radar?
Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the Vanguard Mega Cap ETF (MGC), a passively managed exchange traded fund launched on 12/17/2007.
Analysts Set Expectations for CRSP FY2027 Earnings
Analysts at Zacks Research issued their FY2027 earnings per share (EPS) estimates for CRISPR Therapeutics in a report ...
Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago
Investors in CRISPR Therapeutics AG (NASDAQ:CRSP) have tasted that bitter downside in the last year, as the share price dropped 46%. That contrasts poorly with the market return of 15%. At least the ...
Signs of hiring at Boston-area life sciences companies
Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...
6 Vanguard Index Funds To Buy Now
Explore highly-rated Vanguard index funds for long-term investing and build a well-diversified portfolio. Check our list of ...
CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)
CRISPR Therapeutics AG ( NASDAQ: CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ET ...
Here's what Trump's Cabinet picks have in their investment portfolios — from bitcoin and Big Tech to index funds
Trump's Cabinet members hold diverse portfolios with bitcoin, Big Tech stocks, and index funds.
Prediction: CRISPR Therapeutics Will Beat the Market. Here's Why
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.